Difficulty: Medium
Average Score: 67%
Practice
Tolerance to this inotropic drug develops after a few days:
Correct answer
C
Rationale
In this question, the correct answer is C) Dobutamine. Dobutamine is an inotropic drug commonly used to increase cardiac contractility in conditions such as heart failure or during cardiac surgery. Tolerance to dobutamine can develop after a few days of continuous use. This tolerance occurs due to downregulation of beta-adrenergic receptors in response to the constant stimulation by dobutamine. As a result, higher doses are needed to achieve the same effect, making it less effective over time.
Now, let's analyze why the other options are incorrect:
A) Amrinone: Amrinone is a phosphodiesterase inhibitor that increases contractility by increasing intracellular cAMP levels. While tolerance can develop to its vasodilatory effects, it is not typically associated with rapid tolerance development in terms of its inotropic effects.
B) Amiodarone: Amiodarone is an antiarrhythmic drug used to treat various types of arrhythmias. It does not have direct inotropic effects, so the concept of tolerance to its inotropic effects does not apply.
D) Adenosine: Adenosine is used for the termination of supraventricular tachycardia due to its ability to transiently block AV nodal conduction. It does not have inotropic properties, so tolerance to inotropic effects is not relevant in this context.
Educational Context:
Understanding the development of tolerance to pharmacological agents is crucial in clinical practice. It helps healthcare professionals anticipate changes in drug efficacy over time and make informed decisions regarding dosing adjustments or alternative treatment options. In the case of dobutamine, being aware of the development of tolerance can guide clinicians in monitoring patients closely and adjusting treatment regimens to maintain therapeutic effectiveness.
Now, let's analyze why the other options are incorrect:
A) Amrinone: Amrinone is a phosphodiesterase inhibitor that increases contractility by increasing intracellular cAMP levels. While tolerance can develop to its vasodilatory effects, it is not typically associated with rapid tolerance development in terms of its inotropic effects.
B) Amiodarone: Amiodarone is an antiarrhythmic drug used to treat various types of arrhythmias. It does not have direct inotropic effects, so the concept of tolerance to its inotropic effects does not apply.
D) Adenosine: Adenosine is used for the termination of supraventricular tachycardia due to its ability to transiently block AV nodal conduction. It does not have inotropic properties, so tolerance to inotropic effects is not relevant in this context.
Educational Context:
Understanding the development of tolerance to pharmacological agents is crucial in clinical practice. It helps healthcare professionals anticipate changes in drug efficacy over time and make informed decisions regarding dosing adjustments or alternative treatment options. In the case of dobutamine, being aware of the development of tolerance can guide clinicians in monitoring patients closely and adjusting treatment regimens to maintain therapeutic effectiveness.